July 30, 2016
Recommended Topic Related To:


"This week the U.S. Food and Drug Administration approved Mekinist (trametinib) in combination with Tafinlar (dabrafenib) to treat patients with advanced melanoma that is unresectable (cannot be removed by surgery) or metastatic (late-stage).




Sylatron Consumer

IMPORTANT: HOW TO USE THIS INFORMATION: This is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate for you. This information is not individual medical advice and does not substitute for the advice of your health care professional. Always ask your health care professional for complete information about this product and your specific health needs.


(peg-IN-ter-FEER-on AL-fa too bee)


WARNING: Peginterferon alfa-2b may cause you to develop serious mental/mood changes during treatment and up to 6 months after your last dose of the medication. Tell your doctor right away if you have symptoms such as confusion, depression, suicidal thoughts, unusual irritability, or aggressive behavior. Your doctor may recommend psychiatric therapy and monitoring. Treatment with this medication may be stopped if symptoms are severe. However, these symptoms may not go away even after stopping the medication.

USES: This medication is used to keep malignant melanoma (a type of skin cancer) from coming back after it has been removed by surgery. This medication is the same as a protein that your body naturally makes (interferon). This medication is thought to work by affecting how cells work and grow and by affecting the body's natural defenses (immune system) in many ways. Adding more interferon may help your body fight off cancer.

HOW TO USE: Read the Medication Guide and the Instructions for Use Leaflet provided by your pharmacist before you start using peginterferon alfa-2b and each time you get a refill. If you have any questions, ask your doctor, nurse or pharmacist.

If you are giving this medication to yourself at home, learn all preparation and usage instructions from your health care professional. Gently swirl the vial to dissolve the medication. Do not shake the vial. Before using, check this product visually for particles or discoloration. If either is present, do not use the liquid. Learn how to store and discard medical supplies safely.

Before injecting each dose, clean the injection site with rubbing alcohol. Use a different place each time you give yourself an injection to help lessen injection site soreness.

Inject this medication under the skin (subcutaneously) on your thigh, stomach, or the outer surface of your upper arm, as directed by your doctor, usually once weekly. Do not inject near the belly button or at the waistline.

The dosage is based on your body weight, medical condition, and response to treatment.

Use this medication regularly to get the most benefit from it. Remember to use it on the same day each week. It may help to mark your calendar with a reminder.

If you have flu-like symptoms, drink plenty of fluids while you are using this medication, unless your doctor directs you otherwise.

Sylatron - User Reviews

Sylatron User Reviews

Now you can gain knowledge and insight about a drug treatment with Patient Discussions.

Here is a collection of user reviews for the medication Sylatron sorted by most helpful. Patient Discussions FAQs

Report Problems to the Food and Drug Administration


You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Get the latest treatment options.